145 related articles for article (PubMed ID: 36646017)
1. Cardiovascular disease onset in old people with severe hypercholesterolemia.
Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Krieger JE; Pereira AC; Santos RD
Atherosclerosis; 2023 Jan; 365():9-14. PubMed ID: 36646017
[TBL] [Abstract][Full Text] [Related]
2. Familial hypercholesterolemia and cardiovascular disease in older individuals.
Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Tada MT; Lima IR; Filho WS; Chacra AP; Pereira AC; Krieger JE; Santos RD
Atherosclerosis; 2021 Feb; 318():32-37. PubMed ID: 33450476
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
[TBL] [Abstract][Full Text] [Related]
4. Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy.
Miname MH; Bittencourt MS; Moraes SR; Alves RIM; Silva PRS; Jannes CE; Pereira AC; Krieger JE; Nasir K; Santos RD
JACC Cardiovasc Imaging; 2019 Sep; 12(9):1797-1804. PubMed ID: 30448145
[TBL] [Abstract][Full Text] [Related]
5. Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies.
Pasta A; Cremonini AL; Formisano E; Fresa R; Bertolini S; Pisciotta L
Atherosclerosis; 2020 Sep; 308():6-14. PubMed ID: 32771803
[TBL] [Abstract][Full Text] [Related]
6. Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia.
Paquette M; Cariou B; Bernard S; Hegele RA; Gallo A; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2024 Feb; 44(2):505-512. PubMed ID: 38031840
[TBL] [Abstract][Full Text] [Related]
7. Past, Present, and Future of Familial Hypercholesterolemia Management.
Rocha VZ; Santos RD
Methodist Debakey Cardiovasc J; 2021; 17(4):28-35. PubMed ID: 34824679
[TBL] [Abstract][Full Text] [Related]
8. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
[TBL] [Abstract][Full Text] [Related]
9. Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol.
Zhang Y; Dron JS; Bellows BK; Khera AV; Liu J; Balte PP; Oelsner EC; Amr SS; Lebo MS; Nagy A; Peloso GM; Natarajan P; Rotter JI; Willer C; Boerwinkle E; Ballantyne CM; Lutsey PL; Fornage M; Lloyd-Jones DM; Hou L; Psaty BM; Bis JC; Floyd JS; Vasan RS; Heard-Costa NL; Carson AP; Hall ME; Rich SS; Guo X; Kazi DS; de Ferranti SD; Moran AE
JAMA Cardiol; 2024 Mar; 9(3):263-271. PubMed ID: 38294787
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
[TBL] [Abstract][Full Text] [Related]
11. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
[TBL] [Abstract][Full Text] [Related]
12. Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population-based study.
Tada H; Kaneko H; Suzuki Y; Okada A; Takeda N; Fujiu K; Morita H; Ako J; Node K; Takeji Y; Takamura M; Yasunaga H; Komuro I
Eur J Clin Invest; 2024 Feb; 54(2):e14119. PubMed ID: 37916502
[TBL] [Abstract][Full Text] [Related]
13. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
[TBL] [Abstract][Full Text] [Related]
14. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
[TBL] [Abstract][Full Text] [Related]
15. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Risk Misperception and Low Awareness of Familial Hypercholesterolemia in Individuals with Severe Hypercholesterolemia.
Santos RD; Pereira C; Cesena F; Laurinavicius AG; Tabone V; Bittencourt MS
Arq Bras Cardiol; 2021 Mar; 116(4):706-712. PubMed ID: 33566934
[TBL] [Abstract][Full Text] [Related]
17. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
[TBL] [Abstract][Full Text] [Related]
18. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease.
Hedegaard BS; Bork CS; Kaltoft M; Klausen IC; Schmidt EB; Kamstrup PR; Langsted A; Nordestgaard BG
J Am Coll Cardiol; 2022 Nov; 80(21):1998-2010. PubMed ID: 36396201
[TBL] [Abstract][Full Text] [Related]
19. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
Ogura M; Hori M; Harada-Shiba M
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
[TBL] [Abstract][Full Text] [Related]
20. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
